Volume : 10, Issue : 03, March – 2023
Title:
22.A REVIEW ON BI-LAYERED TABLETS
Authors :
Palivela Durga Chandra Vamshi*, V.Suresh, Brahmaiah Bonthagarala, M.Mohan Varma, K S Nataraj
Abstract :
Bilayer (and multilayer) tablet-based therapeutic strategies are becoming more popular among both brand-name and generic medications as a result of a number of interrelated aspects, such as sophisticated delivery methods, patient compliance, and combination therapy. In order to successfully manufacture these increasingly sophisticated systems, a number of obstacles must be overcome, ranging from formulation design through tablet press monitoring and control. The key advantages of this class of oral dosage forms are highlighted in this article, which also gives a summary of the most recent developments in bilayer tablet technology. It also describes the present obstacles to improving production procedures and product quality.
Keywords: Bilayer tablet technology, generic medication, oral dosage forms
Cite This Article:
Please cite this article in press Palivela Durga Chandra Vamshi et al, A Review On Bilayered Tablets ., Indo Am. J. P. Sci, 2023; 10 (03).
Number of Downloads : 10
References:
1. Martindale, the Extra Pharmacopoeia, 31sted.The Pharmaceutical Press, London; 1996.p.936–937.
2. Shiyani B et al. Formulation and evaluation of bilayer tablet of Metoclopramide hydrochloride and Ibuprofen. AAPS Pharm Sci Tech 2008;9(3):818-27.
3. Pranjal Kumar Singh et al, Sanjoo Kumar et al Bilayer and Floating Bioadhesive Tablets: Innovative approach to Gastroretention, Journal of Drug Delivery & Therapeutics; 2011, 1(1): 32-35
4. Kulkarni A et al, Development and evaluation of bilayer floating tablets of atenolol and lovastatin for biphasic release profile.
5. Panchel hiten ashok, Tiwari ajay kumar, A Novel approach of bilayer tablet technology-A review, IRJP, 3(5), 2012.
6. Nirmal J et al, Saisivam S et al, Peddanna C et al, Muralidharan S et al, Nagarajan M et al, Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation. Chem. Pharm.Bull.2008;56: 1455–1458,26-102-1PB.
7. Varaiya C. Bi-layer neutraceutical tablets: Rewards and challenges. In: Keefer R, Calvin J, Kirsch D, Bubb G, Bowman L, Matthews S. Multi-layer tabletting Q & A. CSC Publishing.
8. Jan Vogeleer et al Bi-layer tablets – why special technology is required The Courtoy-R292F tablet press, designed for quality bi-layer tablets Niro Pharma Systems.
9. Abshagen U et al, Spo ¨rl-Radun S et al, First data on the effects and pharmacokinetics of isosorbide-5- mononitrate in normal man, Eur. J. Clin.Pharmacol.;1981; 19p.423–429.
10. Hutt V et al, Bonn R et al, Fritschi E et al, Jaeger H et al, Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide- 5- mononitrate preparation in healthy volunteers, Arzneim.- Forsch./Drug Res.;1995, p.142–145.
11. Patel Mehul,Ganesh et al, Nanjan Sockan et al, Challenges in the Formulation of Bilayered Tablets: A Review, International Journal of Pharma Research and Development,2010, ISSN 0974 – 9446.
12. Rudnic EM et al, Kottke et al MK Tablet dosage form. In Banker GS, Rhodes CT, editors. Modern Pharmaceutics. 3rd ed., vol 72. New York: Marcel Dekker Inc. p 369.
13. Breech AJ et al, Lucisano L J et al, Franz RM et al Investigation into substrate cracking of a film coated bilayered tablet. J. Pharm.Pharmacol. 1998; 40:282- 283.
14. M.A. Kalam et al, M. Humayun et al, N. Parvez et al, S.Yadav et al, A.Garg et al, S.Amin et al ,Y. Sultana et al and A. Ali.,Continental et al J. Pharmaceutical Sciences;2007,1: 30 – 35
15. Li S.P. et al, Karth M.G. et al, Feld K.M. et al, Pendharkar C.M. et al, Willams R.O. et al, Evaluation of Bilayer tablet machines. A Case study. Drug Dev. Ind. Pharm. 1995; 21(5): 571 590.
16. Naisarg d. Pujara ronak k. Gokani, Jalpa s. paun. Bilayer tablet –An emerging trend ijprd, 2011; vol 4(04): june-2012 (102 – 111).
17. Shirwalkar A A, Kumar SM, Jacob S. Recent developments in floating drug delivery systems for gastric retention of drugs, an overview. Indian drugs. 2006; 43(9): 697-704.
18. Jamunadhevi V, Sahoo P K and Kailasam P. Formulation and in vitro evaluation of bi-layer tablet of cyclobenzaprine hydrochloride ER and diclofenac potassium IR- A novel fixed dose combination. Int J Res Pharm Sci 2011; 2(2):170-8.
19. Swamy P V, Kinagi M B, Biradar S S, Gada S N and Shilpa H. Formulation design and evaluation of bilayer buccal tablets of granisetron hydrochloride. Ind J Pharm Edu Res 2011; 45(3):242-7.
20. Pattanayak D P and Dinda S C. Bilayer tablet formulation of Metformin HCl and Glimepiride:A novel approach to improve therapeutic efficacy. Int J Drug Discovery Herb Res 2011; 1(1):1-4.
21. Jain J, Marya B H, Mittal RP and Patel M. Formulation and evaluation of indomethacin bilayer sustained release tablets. Int J PharmTech Res 2011; 3(2):1132-8.
22. Mohindeen S, Jyothi B, Pavani S, Satyanarayana T, Kumar SP and Krishna NS. Formulation and evaluation of bilayered tablets of metformin hydrochloride and atorvastatin calcium. Int J Pharm Sci Rev Res 2011; 10(2):130-4.